Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$4.25
-6.8%
$4.58
$3.31
$8.80
$1.58B1.245.68 million shs4.07 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
-6.80%-16.99%-15.00%+10.97%-48.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
3.3389 of 5 stars
3.21.00.00.03.02.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
2.45
Hold$5.8036.47% Upside

Current Analyst Ratings Breakdown

Latest GDRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2025
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$6.00
8/8/2025
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Outperform
(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$792.32M1.86$0.30 per share14.33$1.89 per share2.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$16.39M$0.1042.5023.611.994.33%8.86%4.50%11/6/2025 (Estimated)

Latest GDRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$0.10$0.09-$0.01$0.04$205.72 million$203.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
0.75
4.21
4.21

Institutional Ownership

CompanyInstitutional Ownership
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
63.77%

Insider Ownership

CompanyInsider Ownership
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
4.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
950347.45 million332.96 millionOptionable

Recent News About These Companies

GoodRx (NASDAQ:GDRX) Shares Gap Up - What's Next?
Why GoodRx (GDRX) Stock Is Trading Up Today
Stock Movers: Novo Nordisk, GoodRX, CVS
Citi Keeps Their Buy Rating on GoodRx Holdings (GDRX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

GoodRx stock logo

GoodRx NASDAQ:GDRX

$4.25 -0.31 (-6.80%)
Closing price 08/25/2025 04:00 PM Eastern
Extended Trading
$4.24 -0.01 (-0.24%)
As of 08/25/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.